{"id":9645,"date":"2022-08-01T16:10:00","date_gmt":"2022-08-01T14:10:00","guid":{"rendered":"https:\/\/irlab.se\/mfn_news\/forandrat-antal-aktier-och-roster-i-irlab-therapeutics-ab\/"},"modified":"2022-08-01T16:10:00","modified_gmt":"2022-08-01T14:10:00","slug":"forandrat-antal-aktier-och-roster-i-irlab-therapeutics-ab","status":"publish","type":"mfn_news","link":"https:\/\/irlab.se\/sv\/mfn_news\/forandrat-antal-aktier-och-roster-i-irlab-therapeutics-ab\/","title":{"rendered":"F\u00f6r\u00e4ndrat antal aktier och r\u00f6ster i IRLAB Therapeutics AB"},"content":{"rendered":"

[mfn_before_post]<\/p>\n

\n

IRLAB (Nasdaq Stockholm: IRLAB A) meddelade idag att antalet aktier och r\u00f6ster i IRLAB Therapeutics AB har f\u00f6r\u00e4ndrats till f\u00f6ljd av den apportemission av 120 000 aktier av serie A, vilken genomf\u00f6rdes i april 2022.<\/strong><\/p>\n<\/div>\n

\n

Det \u00f6kade antalet aktier registrerades av Bolagsverket under juli 2022. Genom apportemissionen har antalet r\u00f6ster och utest\u00e5ende aktier av serie A \u00f6kat med 120 000, fr\u00e5n 51 668 630 till 51 788 630. Antalet aktier av serie B uppg\u00e5r of\u00f6r\u00e4ndrat till 79 776. Totalt uppg\u00e5r antalet aktier och r\u00f6ster efter f\u00f6r\u00e4ndringen till 51 868 406. Aktiekapitalet har genom apportemissionen \u00f6kat med 2 400 kr fr\u00e5n 1 034 968,12 till 1 037 368,12 kronor.<\/p>\n

F\u00f6r mer information om apportemissionen h\u00e4nvisas till pressmeddelandet fr\u00e5n den 22 april: IRLAB f\u00f6rv\u00e4rvar know-how kopplad till P003-projektet som \u00e4r inriktat mot innovativ behandling av Parkinsons sjukdom.<\/em><\/p>\n<\/div>\n

\n

F\u00f6r mer information<\/strong><\/p>\n

\n

Viktor Siewertz, CFO
Tel: +46 727 10 70 70
E-post:\u00a0viktor.siewertz@irlab.se<\/a><\/p>\n<\/div>\n

\n

Denna information \u00e4r s\u00e5dan information som IRLAB Therapeutics \u00e4r skyldigt att offentligg\u00f6ra enligt lagen om handel med finansiella instrument. Informationen l\u00e4mnades f\u00f6r offentligg\u00f6rande den 2022-08-01 16:10 CEST.<\/em><\/p>\n<\/div>\n

\n

Om IRLAB<\/strong><\/p>\n

\n

IRLAB uppt\u00e4cker och utvecklar nya l\u00e4kemedel f\u00f6r behandling av Parkinsons sjukdom och andra sjukdomar i hj\u00e4rnan. Bolagets l\u00e4ngst framskridna l\u00e4kemedelskandidater, mesdopetam (IRL790) och pirepemat (IRL752) \u00e4r b\u00e5da i Fas IIb och \u00e4r designade f\u00f6r att behandla n\u00e5gra av de sv\u00e5raste symtomen relaterade till Parkinsons sjukdom. Under 2021 ingick IRLAB ett exklusivt och globalt licensavtal med Ipsen f\u00f6r utveckling och marknadsf\u00f6ring av mesdopetam.
\u00a0
Genom den egenutvecklade forskningsplattformen ISP (Integrative Screening Process) har IRLAB uppt\u00e4ckt och utvecklat alla sina projekt och forts\u00e4tter att uppt\u00e4cka innovativa l\u00e4kemedelskandidater f\u00f6r behandling av sjukdomar relaterade till det centrala nervsystemet. F\u00f6rutom IRLAB:s starka kliniska pipeline driver IRLAB ett flertal prekliniska program d\u00e4r IRL942 och IRL757 \u00e4r i utveckling f\u00f6r Fas I. IRLAB \u00e4r noterat p\u00e5 Nasdaq Stockholms huvudlista. Mer information p\u00e5\u00a0www.irlab.se.<\/a><\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

F\u00f6r\u00e4ndrat antal aktier och r\u00f6ster i IRLAB Therapeutics AB<\/a><\/p>\n<\/div>\n

[mfn_after_post]<\/p>\n","protected":false},"excerpt":{"rendered":"

IRLAB (Nasdaq Stockholm: IRLAB A) meddelade idag att antalet aktier och r\u00f6ster i IRLAB Therapeutics AB har f\u00f6r\u00e4ndrats till f\u00f6ljd av den apportemission av 120 000 aktier av serie A, vilken genomf\u00f6rdes i april 2022.<\/p>\n","protected":false},"template":"","class_list":["post-9645","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ca-shares_sv","mfn-news-tag-mfn-ca_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn-regulatory-lhfi_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-regulatory_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nF\u00f6r\u00e4ndrat antal aktier och r\u00f6ster i IRLAB Therapeutics AB - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/mfn_news\/forandrat-antal-aktier-och-roster-i-irlab-therapeutics-ab\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"F\u00f6r\u00e4ndrat antal aktier och r\u00f6ster i IRLAB Therapeutics AB - IRLAB\" \/>\n<meta property=\"og:description\" content=\"IRLAB (Nasdaq Stockholm: IRLAB A) meddelade idag att antalet aktier och r\u00f6ster i IRLAB Therapeutics AB har f\u00f6r\u00e4ndrats till f\u00f6ljd av den apportemission av 120 000 aktier av serie A, vilken genomf\u00f6rdes i april 2022.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/mfn_news\/forandrat-antal-aktier-och-roster-i-irlab-therapeutics-ab\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/forandrat-antal-aktier-och-roster-i-irlab-therapeutics-ab\/\",\"url\":\"https:\/\/irlab.se\/mfn_news\/forandrat-antal-aktier-och-roster-i-irlab-therapeutics-ab\/\",\"name\":\"F\u00f6r\u00e4ndrat antal aktier och r\u00f6ster i IRLAB Therapeutics AB - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2022-08-01T14:10:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/mfn_news\/forandrat-antal-aktier-och-roster-i-irlab-therapeutics-ab\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/mfn_news\/forandrat-antal-aktier-och-roster-i-irlab-therapeutics-ab\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/forandrat-antal-aktier-och-roster-i-irlab-therapeutics-ab\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\/\/irlab.se\/sv\/pressmeddelanden\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"F\u00f6r\u00e4ndrat antal aktier och r\u00f6ster i IRLAB Therapeutics AB\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson's disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"F\u00f6r\u00e4ndrat antal aktier och r\u00f6ster i IRLAB Therapeutics AB - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/mfn_news\/forandrat-antal-aktier-och-roster-i-irlab-therapeutics-ab\/","og_locale":"sv_SE","og_type":"article","og_title":"F\u00f6r\u00e4ndrat antal aktier och r\u00f6ster i IRLAB Therapeutics AB - IRLAB","og_description":"IRLAB (Nasdaq Stockholm: IRLAB A) meddelade idag att antalet aktier och r\u00f6ster i IRLAB Therapeutics AB har f\u00f6r\u00e4ndrats till f\u00f6ljd av den apportemission av 120 000 aktier av serie A, vilken genomf\u00f6rdes i april 2022.","og_url":"https:\/\/irlab.se\/mfn_news\/forandrat-antal-aktier-och-roster-i-irlab-therapeutics-ab\/","og_site_name":"IRLAB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/mfn_news\/forandrat-antal-aktier-och-roster-i-irlab-therapeutics-ab\/","url":"https:\/\/irlab.se\/mfn_news\/forandrat-antal-aktier-och-roster-i-irlab-therapeutics-ab\/","name":"F\u00f6r\u00e4ndrat antal aktier och r\u00f6ster i IRLAB Therapeutics AB - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2022-08-01T14:10:00+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/mfn_news\/forandrat-antal-aktier-och-roster-i-irlab-therapeutics-ab\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/mfn_news\/forandrat-antal-aktier-och-roster-i-irlab-therapeutics-ab\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/mfn_news\/forandrat-antal-aktier-och-roster-i-irlab-therapeutics-ab\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/irlab.se\/sv\/pressmeddelanden\/"},{"@type":"ListItem","position":3,"name":"F\u00f6r\u00e4ndrat antal aktier och r\u00f6ster i IRLAB Therapeutics AB"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson's disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news\/9645","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=9645"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}